Circadian clock-deficient mice as a tool for exploring disease etiology

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 9, 2012, Pages 1385-1391

  Doi, Masao ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Aldosterone; Circadian clock; Clock gene; Hypertension

Indexed keywords

ALDOSTERONE; CRYPTOCHROME 1; CRYPTOCHROME 2; HSD3B6 PROTEIN; HYDROXYSTEROID DEHYDROGENASE; PROTEIN BMAL1; UNCLASSIFIED DRUG;

AUTOREGULATION; CIRCADIAN RHYTHM; CRY1 GENE; CRY2 GENE; DIABETES MELLITUS; GENETIC LINKAGE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; IDIOPATHIC HYPERALDOSTERONISM; MOLECULAR CLOCK; NEOPLASM; NONHUMAN; OBESITY; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIMARY HYPERALDOSTERONISM; REVIEW; SALT SENSITIVE HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP AROUSAL DISORDER; SUPRACHIASMATIC NUCLEUS; ZONA FASCICULATA; ZONA GLOMERULOSA;

EID: 84866027806     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00364     Document Type: Review

References (62)

1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell, 104, 545-556 (2001).
2. Furlan R, Barbic F, Piazza S, Tinelli M, Seghizzi P, Malliani A. Modifications of cardiac autonomic profile associated with a shift schedule of work. Circulation, 102, 1912-1916 (2000).
3. Bradley TD, Floras JS. Sleep apnea and heart failure: Part II: central sleep apnea. Circulation, 107, 1822-1826 (2003).
4. Suwazono Y, Dochi M, Sakata K, Okubo Y, Oishi M, Tanaka K, Kobayashi E, Nogawa K. Shift work is a risk factor for increased blood pressure in Japanese men: a 14-year historical cohort study. Hypertension, 52, 581-586 (2008).
5. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl. Acad. Sci. U.S.A., 106, 4453-4458 (2009).
6. Doi M, Takahashi Y, Komatsu R, Yamazaki F, Yamada H, Haraguchi S, Emoto N, Okuno Y, Tsujimoto G, Kanematsu A, Ogawa O, Todo T, Tsutsui K, van der Horst GTJ, Okamura H. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat. Med., 16, 67-74 (2010).
7. Rossier BC, Schild L. Epithelial sodium channel: mendelian versus essential hypertension. Hypertension, 52, 595-600 (2008).
8. Kaplan NM. Primary aldosteronism. Clinical hypertension, Lippincott Williams & Wilkins, Philadelphia, PA, pp. 410-433 (2006).
9. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin. Endocrinol. (Oxf.), 66, 607-618 (2007).
10. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat. Rev. Genet., 9, 764-775 (2008).
11. Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat. Rev. Cancer, 9, 886-896 (2009).
12. Liu AC, Lewis WG, Kay SA. Mammalian circadian signaling networks and therapeutic targets. Nat. Chem. Biol., 3, 630-639 (2007).
13. Schibler U, Sassone-Corsi P. A web of circadian pacemakers. Cell, 111, 919-922 (2002).
14. Silver R, LeSauter J, Tresco PA, Lehman MN. A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature, 382, 810-813 (1996).
15. Ralph MR, Foster RG, Davis FC, Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science, 247, 975-978 (1990).
16. Okamura H. Suprachiasmatic nucleus clock time in the mammalian circadian system. Cold Spring Harb. Symp. Quant. Biol., 72, 551-556 (2007).
17. Doi M, Ishida A, Miyake A, Sato M, Komatsu R, Yamazaki F, Kimura I, Tsuchiya S, Kori H, Seo K, Yamaguchi Y, Matsuo M, Fustin J-M, Tanaka R, Santo Y, Yamada H, Takahashi Y, Araki M, Nakao K, Aizawa S, Kobayashi M, Obrietan K, Tsujimoto G, Okamura H. Circadian regulation of intracellular G-protein signalling mediates intercellular synchrony and rhythmicity in the suprachiasmatic nucleus. Nat. Commun., 2, 327 (2011).
18. Sujino M, Masumoto KH, Yamaguchi S, van der Horst GT, Okamura H, Inouye ST. Suprachiasmatic nucleus grafts restore circadian behavioral rhythms of genetically arrhythmic mice. Curr. Biol., 13, 664-668 (2003).
19. Ripperger JA, Schibler U. Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat. Genet., 38, 369-374 (2006).
20. Etchegaray JP, Lee C, Wade PA, Reppert SM. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature, 421, 177-182 (2003).
21. Doi M, Hirayama J, Sassone-Corsi P. Circadian regulator CLOCK is a histone acetyltransferase. Cell, 125, 497-508 (2006).
22. Hogenesch JB, Ueda HR. Understanding systems-level properties: timely stories from the study of clocks. Nat. Rev. Genet., 12, 407-416 (2011).
23. Yamaguchi S, Mitsui S, Yan L, Yagita K, Miyake S, Okamura H. Role of DBP in the circadian oscillatory mechanism. Mol. Cell. Biol., 20, 4773-4781 (2000).
24. Doi M, Nakajima Y, Okano T, Fukada Y. Light-induced phase-delay of the chicken pineal circadian clock is associated with the induction of cE4bp4, a potential transcriptional repressor of cPer2 gene. Proc. Natl. Acad. Sci. U.S.A., 98, 8089-8094 (2001).
25. Mitsui S, Yamaguchi S, Matsuo T, Ishida Y, Okamura H. Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism. Genes Dev., 15, 995-1006 (2001).
26. Doi M, Okano T, Yujnovsky I, Sassone-Corsi P, Fukada Y. Negative control of circadian clock regulator E4BP4 by casein kinase Iepsilon-mediated phosphorylation. Curr. Biol., 14, 975-980 (2004).
27. Ueda HR, Hayashi S, Chen W, Sano M, Machida M, Shigeyoshi Y, Iino M, Hashimoto S. System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat. Genet., 37, 187-192 (2005).
28. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell, 109, 307-320 (2002).
29. Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, Weitz CJ. Extensive and divergent circadian gene expression in liver and heart. Nature, 417, 78-83 (2002).
30. Akhtar RA, Reddy AB, Maywood ES, Clayton JD, King VM, Smith AG, Gant TW, Hastings MH, Kyriacou CP. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr. Biol., 12, 540-550 (2002).
31. Jin X, Shearman LP, Weaver DR, Zylka MJ, de Vries GJ, Reppert SM. A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell, 96, 57-68 (1999).
32. Lavery DJ, Lopez-Molina L, Margueron R, Fleury-Olela F, Conquet F, Schibler U, Bonfils C. Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP. Mol. Cell. Biol., 19, 6488-6499 (1999).
33. Ueda HR, Chen W, Adachi A, Wakamatsu H, Hayashi S, Takasugi T, Nagano M, Nakahama K, Suzuki Y, Sugano S, Iino M, Shigeyoshi Y, Hashimoto S. A transcription factor response element for gene expression during circadian night. Nature, 418, 534-539 (2002).
34. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptácek LJ, Fu YH. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science, 291, 1040-1043 (2001).
35. Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, Saigoh K, Ptácek LJ, Fu YH. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature, 434, 640-644 (2005).
36. He Y, Jones CR, Fujiki N, Xu Y, Guo B, Holder JL Jr, Rossner MJ, Nishino S, Fu YH. The transcriptional repressor DEC2 regulates sleep length in mammals. Science, 325, 866-870 (2009).
37. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell, 111, 41-50 (2002).
38. Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, Laposky A, Losee-Olson S, Easton A, Jensen DR, Eckel RH, Takahashi JS, Bass J. Obesity and metabolic syndrome in circadian Clock mutant mice. Science, 308, 1043-1045 (2005).
39. Rudic RD, McNamara P, Curtis AM, Boston RC, Panda S, Hogenesch JB, Fitzgerald GA. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol., 2, e377 (2004).
40. Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, Ko CH, Ivanova G, Omura C, Mo S, Vitaterna MH, Lopez JP, Philipson LH, Bradfield CA, Crosby SD, JeBailey L, Wang X, Takahashi JS, Bass J. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature, 466, 627-631 (2010).
41. Shimba S, Ogawa T, Hitosugi S, Ichihashi Y, Nakadaira Y, Kobayashi M, Tezuka M, Kosuge Y, Ishige K, Ito Y, Komiyama K, Okamatsu-Ogura Y, Kimura K, Saito M. Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS ONE, 6, e25231 (2011).
42. Hashiramoto A, Yamane T, Tsumiyama K, Yoshida K, Komai K, Yamada H, Yamazaki F, Doi M, Okamura H, Shiozawa S. Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alpha. J. Immunol., 184, 1560-1565 (2010).
43. Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, Maywood ES, Hastings MH, Reppert SM. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell, 98, 193-205 (1999).
44. Okamura H, Miyake S, Sumi Y, Yamaguchi S, Yasui A, Muijtjens M, Hoeijmakers JH, van der Horst GT. Photic induction of mPer1 and mPer2 in cry-deficient mice lacking a biological clock. Science, 286, 2531-2534 (1999).
45. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science, 302, 255-259 (2003).
46. Ripperger JA, Shearman LP, Reppert SM, Schibler U. CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP. Genes Dev., 14, 679-689 (2000).
47. Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch JB, Simon MC, Takahashi JS, Bradfield CA. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell, 103, 1009-1017 (2000).
48. Curtis AM, Cheng Y, Kapoor S, Reilly D, Price TS, Fitzgerald GA. Circadian variation of blood pressure and the vascular response to asynchronous stress. Proc. Natl. Acad. Sci. U.S.A., 104, 3450-3455 (2007).
49. van der Horst GT, Muijtjens M, Kobayashi K, Takano R, Kanno S, Takao M, de Wit J, Verkerk A, Eker AP, van Leenen D, Buijs R, Bootsma D, Hoeijmakers JH, Yasui A. Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. Nature, 398, 627-630 (1999).
50. Yagita K, Tamanini F, van Der Horst GT, Okamura H. Molecular mechanisms of the biological clock in cultured fibroblasts. Science, 292, 278-281 (2001).
51. Vitaterna MH, Selby CP, Todo T, Niwa H, Thompson C, Fruechte EM, Hitomi K, Thresher RJ, Ishikawa T, Miyazaki J, Takahashi JS, Sancar A. Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc. Natl. Acad. Sci. U.S.A., 96, 12114-12119 (1999).
52. Masuki S, Todo T, Nakano Y, Okamura H, Nose H. Reduced alpha-adrenoceptor responsiveness and enhanced baroreflex sensitivity in Cry-deficient mice lacking a biological clock. J. Physiol., 566, 213-224 (2005).
53. Potts GO, Creange JE, Hardomg HR, Schane HP. Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids, 32, 257-267 (1978).
54. Jungmann E, Magnet W, Rottmann-Kuhnke U, Sprey R, Schwedes U, Usadel KH, Schöffling K. The inhibiting effect of trilostane on adrenal steroid synthesis: hormonal and morphological alterations induced by subchronic trilostane treatment in normal rats. Res. Exp. Med., 180, 193-200 (1982).
55. Nakada T, Kazama T, Koike H, Yoshikawa M, Ishikawa S, Katayama T. Primary aldosteronism treated by trilostane (3,β-hydroxysteroid dehydrogenase inhibitor). Urology, 25, 207-214 (1985).
56. Winterberg B, Vetter W, Groth H, Greminger P, Vetter H. Primary aldosteronism: treatment with trilostane. Cardiology, 72 (Suppl. 1), 117-121 (1985).
57. Wang Q, Maillard M, Schibler U, Burnier M, Gachon F. Cardiac hypertrophy, low blood pressure, and low aldosterone levels in mice devoid of the three circadian PAR bZip transcription factors DBP, HLF, and TEF. Am. J. Physiol. Regul. Integr. Comp. Physiol., 299, R1013-R1019 (2010).
58. Simard J, Ricketts ML, Gingras S, Soucy P, Feltus FA, Melner MH. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr. Rev., 26, 525-582 (2005).
59. Rosmond R, Chagnon M, Bouchard C, Björntorp P. Polymorphism in exon 4 of the human 3 beta-hydroxysteroid dehydrogenase type I gene (HSD3B1) and blood pressure. Biochem. Biophys. Res. Commun., 293, 629-632 (2002).
60. Shimodaira M, Nakayama T, Sato N, Aoi N, Sato M, Izumi Y, Soma M, Matsumoto K. Association of HSD3B1 and HSD3B2 gene polymorphisms with essential hypertension, aldosterone level, and left ventricular structure. Eur. J. Endocrinol., 163, 671-680 (2010).
61. Funder JW. Minireview: Aldosterone and mineralocorticoid receptors: past, present, and future. Endocrinology, 151, 5098-5102 (2010).
62. Gordon RD, Laragh JH, Funder JW. Low renin hypertensive states: perspectives, unsolved problems, future research. Trends Endocrinol. Metab., 16, 108-113 (2005).